Comprehensive Medical Weight Loss
These days, there’s a lot of buzz around the new injectable weight loss medications. Wegovy® and Zepbound™ are making headlines because they help people lose a lot of weight—15% and 20% of body weight, respectively—and they even help with health…
On February 21st, 2025, the FDA declared that semaglutide (Wegovy / Ozempic) is no longer in shortage. This will have significant impact for patients currently being treated with compounded semaglutide. Read on to learn more about this decision, and about…
Phentermine and Tenuate (diethylpropion) were approved by the FDA for weight loss in 1959. Until recently, they were the main medications we used to help patients lose weight and keep it off. Over the past 2 years, it’s tough to…
It has been an exciting summer for our new GLP-1 weight loss medications, Wegovy (semaglutide) and Zepbound (tirzepatide). This information is current as of 9 Semaglutide At this time, all doses of Wegovy are available at retail pharmacies. Further, all…
Unless you live under a rock, by now you’ve heard of semaglutide – the weekly weight loss injection. But how does semaglutide stack up against the first-ever weight loss medication, phentermine? History of Semaglutide and Phentermine Semaglutide was developed by…
There are two new heavyweights (? lightweights) in town duking it out to help people lose weight and keep it off: semaglutide and tirzepatide. How do semaglutide and tirzepatide for weight loss stack up? How do semaglutide and tirzepatide work?…
Today, November 11th 2023, represents a tipping point in the treatment of obesity. For decades, doctors have viewed obesity as a cosmetic issue, and have resisted treating it with medications due to safety concerns prompted by drugs of old like…
For the first time in the history of obesity medicine, a drug has been shown to lower the risk of heart attack and stroke by 20%. For decades, doctors have helped patients reduce their cardiovascular risk by prescribing medications for…
Wegovy Novo Nordisk has announced that they are no longer able to meet the demand in the US marketplace for Wegovy. To ensure people on Wegovy can get their medication, they are prioritizing access to the highest strengths (1.7 mg…
The FDA has approved a very exciting medication called Mounjaro™. Although approved for treatment of type 2 diabetes, a side effect of Mounjaro™ is weight loss. The same molecule, tirzapeptide, is being researched for weight loss as well. Mounjaro™ is…
